MT-2990

· Tanabe Pharma Corporation

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MT-2990, covering 2024-07-10 to 2026-02-04. Get the full timeline:

Most recent: Clinical Trial Update: An Exploratory Study of MT-2990 in Patients With AAV [Phase 1]